Bioasis has brought together a team of exceptional leaders from the biopharmaceutical industry. Their experience in collaborative research, drug development, alliances and commercialization provides the vision and expertise to enable Bioasis to revolutionize the treatment of neurological diseases.
Mark Day, Ph.D.
President and Chief Executive Officer
Christopher P. Lowe, M.B.A.
Chief Financial Officer
Mei Mei Tian, Ph.D.
Vice President, Head of External Research
Doug Williams, M.B.A.
Executive Vice President and Chief Business Officer
Executive Vice President, Head of Corporate Communications and Investor Relations
Director, Investor Relations
Judi Dalling, LLB